PTC Therapeutics (PTCT) Receives a Hold from TD Cowen
TD Cowen analyst Joseph Thome maintained a Hold rating on PTC Therapeutics (PTCT – Research Report) today and set a price target of $50.00. The ...
American Association of Individual Investors20m
Which Is a Better Investment, Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. Stock?
Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Cowen raises PTC Therapeutics stock price target to $50
Investors and market watchers will likely monitor PTC Therapeutics (NASDAQ:PTCT) closely to see if the company's performance aligns with Cowen's projections and to gauge the potential impact of this ...
Biogen (BIIB) Gets a Buy from RBC Capital
In a report released today, Brian Abrahams from RBC Capital maintained a Buy rating on Biogen (BIIB – Research Report), with a price target of ...
Hosted on MSN23h
Novartis to Report Q4 Earnings: What's in the Offing?
Novartis AG NVS, a Swiss pharma giant, is scheduled to report fourth-quarter 2024 and full-year results on Jan. 31, 2025. The ...
High Growth Tech Stocks to Watch in January 2025
The United States market has shown a flat performance over the last week, yet it impressively rose by 24% in the past year with earnings expected to grow by 15% annually. In this context of robust ...